Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ECVIFOR
- Development stage
- Unknown
- Lead developer
- NI-THE
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**ECVIFOR** is an approved NI-THE oral fixed-dose hematinic product containing ferrous fumarate with ascorbic acid, nicotinamide, thiamine, and additional vitamins listed by the manufacturer. It is intended for anemia and vitamin-deficiency states. Ferrous fumarate supplies elemental iron for hemoglobin synthesis and restoration of iron stores, while ascorbic acid supports gastrointestinal iron absorption and the vitamin components support erythropoiesis and cellular metabolic functions. ([ni-the.com](https://ni-the.com/en/products/))
- Brand names
- ECVIFOR
Beyond the preview
Go deeper on ECVIFOR.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ECVIFOR.